Skip to main content
Log in

Immunoreactive prolactin like material in the urine of women

  • Published:
Journal of Endocrinological Investigation Aims and scope Submit manuscript

Abstract

Immunoreactive prolactin-like material (Ir Prl) was detected in urines of eugonadal women during the luteal phase and in urines of pregnant and lactating women. The levels of Ir Prl urinary excretion per 24 h and of elimination per 100 ml of glomerular filtrate were highest in lactating women as compared to pregnant women; levels in pregnant women were elevated as compared to eugonadal subjects. Iv injection of thyrotropin releasing hormone (TRH, 200 μg) caused increased levels of urinary Ir Prl. The physicochemical characteristics of urinary Ir Prl of lactating women were investigated by filtrating urine samples on Ultragel Aca 54 in presence or absence of Trasylol. Urines, supplemented with Trasylol and analyzed either immediately or after storage at room temperature for 24 h, contained in addition to the 23,000 Mr monomeric form (25.2+7.4%), two fractions of high (≥ 70,000) or low (< 23,000) molecular weight, respectively. The latter material largely predominated (73.5±7.3%). Urines kept at room temperature for 24 h without Trasylol showed variable but significant decreases in the monomer form with a parallel increase in high MW and fragmented forms. The extent of degradation of the monomer was directly proportional to the proteolytic activity of the urines as estimated by the Azocoll breakdown test. Contrary to what was observed with the urinary endogenous monomeric Prl, human pituitary Prl.remained unaltered upon incubation in Trasylol-free urines up to 45 h. These experiments suggest that Prl when it is excreted in the urine, undergoes varying modifications which give rise to immunoreactive aggregates, fragments and a material of normal molecular weight but of high sensitivity to the action of the urinary proteases.

This is a preview of subscription content, log in via an institution to check access.

Access this article

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Similar content being viewed by others

References

  1. Garnier P.E., Aubert M.L., Kaplan S.L., Grumbach H.M. Heterogeneity of pituitary and plasma prolactin in man: decreased affinity of “big prolactin” in a radioreceptor assay and evidence for its secretion. J. Clin. Endocrinol. Metab. 47: 1273, 1978.

    Article  CAS  PubMed  Google Scholar 

  2. Suh H.K., Frantz A.G. Size heterogeneity of human prolactin in plasma and pituitary extracts. J. Clin. Endocrinol. Metab. 39: 928, 1974.

    Article  CAS  PubMed  Google Scholar 

  3. Friesen H.G. Prolactin determination by radioimmunoreceptor and bioassays. Proceedings of the 3rd International Meeting on human prolactin, Athènes, October 1981.

    Google Scholar 

  4. Rogol A.D., Rosen S.W. Prolactin of apparent large molecular size: the major immunoreactive prolactin component in plasma of a patient with a pituitary tumor. J. Clin. Endocrinol. Metab. 38: 714, 1974.

    Article  CAS  PubMed  Google Scholar 

  5. Suh H.K., Frantz A.G. Big and little prolactin in human plasma. Clin. Res. 21: 960, 1973.

    Google Scholar 

  6. Guyda H.J., Whyte S. Big prolactin (bPRL): “in vitro” secretion and radioreceptor activity (RRA) in serum. Clin. Res. 22: 341, 1974.

    Google Scholar 

  7. Guyda H.J. Heterogeneity of human growth hormone and prolactin secreted “in vitro”: immunoassay and radioreceptor assay correlations. J. Clin. Endocrinol. Metab. 41: 953, 1975.

    Article  CAS  PubMed  Google Scholar 

  8. Kataoka K., Imai Y., Hollander C.S. Altered heterogeneity of circulating prolactin following thyrotropin releasing hormone. Clin. Res. 23: 238, 1975.

    Google Scholar 

  9. Whitaker M.D., Klee G.G., Kao P.C., Randall R.V., Heser D.W. Demonstration of biological activity of prolactin molecular weight variants in human sera. J. Clin. Endocrinol. Metab. 58: 826, 1983.

    Article  Google Scholar 

  10. Gala R.R., Singhakowinta A., Brennan M.J. Studies on prolactin in human serum, urine and milk. Horm. Res. 6: 310, 1975.

    Article  CAS  PubMed  Google Scholar 

  11. Sinha Y.N., Selby F.W., Vanderlaan W.P. Radioimmunoassay of prolactin in the urine of mouse and man. J. Clin. Endocrinol. Metab. 36: 1039, 1973.

    Article  CAS  PubMed  Google Scholar 

  12. Goldhaber G., Shani J. Direct radioimmunoassay of human prolactin in semen, serum and urine. J. Endocrinol. 72: 391, 1977.

    Article  CAS  PubMed  Google Scholar 

  13. Reuter A.M., Kennes F., Vrindts-Gevaert Y., Franchimont P. Homologous radioimmunoassay for human prolactin. Int.J. Nucl. Med. Biol. 3: 21, 1976.

    Article  CAS  PubMed  Google Scholar 

  14. Franchimont P., Hendrick J.C., Bourguignon J.P., Reuter A.M. Pitfalls in peptide radioimmunoassays. In: Odell W.D., Franchimont P. (Eds.), Principles of competitive protein-binding assays. John Wiley and Sons, New York, 1981, p. 149.

    Google Scholar 

  15. Cooper D.S., Ridgway E.C., Kliman B., Kjellberg R.N., Maloof F. Metabolic clearance and production rate of prolactin in man. J.Clin. Invest. 64: 1669, 1979.

    Article  CAS  PubMed Central  PubMed  Google Scholar 

  16. Falconer I.R., Vacek A.T. Degradation of prolactin by the mammalian kidney. In: Tolis G., Stefanis C., Mountokalakis T., Labrie F. (Eds.), Prolactin and prolactinomas. Raven Press, New York, 1983, p. 231.

    Google Scholar 

  17. Lim V.S., Frohman L.A. Pathogenesis of hyperprolactinemia in chronic renal failure. In: In: Tolis G., Stefanis C., Mountokalakis T., Labrie F. (Eds.), Prolactin and prolactinomas. Raven Press, New York, 1983, p. 265.

    Google Scholar 

Download references

Author information

Authors and Affiliations

Authors

Additional information

This work is supported by grant no. 3.4501.80 from Belgian Foundation for Medical Research (F.R.S.M.)

Rights and permissions

Reprints and permissions

About this article

Cite this article

Ghuysen, V., Van Cauwenberge, J.R., Reuter, A. et al. Immunoreactive prolactin like material in the urine of women. J Endocrinol Invest 8, 349–355 (1985). https://doi.org/10.1007/BF03348512

Download citation

  • Received:

  • Accepted:

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.1007/BF03348512

Key-words

Navigation